Carmat SA ALCAR.PA
€0.10 €0.00 (0.40%) 1D
Last Updated: Sep 24, 12:00 AM·XPAR
ALCAR.PA Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: July 22, 2025
Report Source: 2024 Annual Report
Carmat SA. Stock Analysis ALCAR.PA
France Health Care Nano Cap Report: Carmat SA is a medtech that designs, manufactures and markets the Aeson artificial heart. The company is headquartered in Velizy-Villacoublay, Ile-De-France and currently employs 153 full-time employees. The company went IPO on 2010-07-07. The firm is developing an orthotopic and biocompatible artificial heart which works like a natural heart, and which is hydraulically activated. The company specializes in the development of a fully implantable orthotopic artificial heart, its electrical power supply system, and its telediagnosis system. The firm formed a network of partnerships with hospitals and various scientific companies, such as The Georges Pompidou European Hospital, The Marie Lannelongue Surgical Center, The Hospital Charles Nicolle of Rouen, Dedienne Sante, PaxiTech, Vignal Artru Industries, French Vessels, and Blood Institute, Laboratoire de Recherche Biochirurgicale and others.
Read More Carmat SA (ALCAR.PA) Chart
Key Statistics of Carmat SA (ALCAR.PA)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
€0.10Volume
806.32KP/E Ratio (TTM)
-52 Week Range
Market Cap
6.35MAvg. Volume
806.32KDividend Yield
-Financial Metrics & Statements of Carmat SA (ALCAR.PA)
FAQ's for Carmat SA (ALCAR.PA)
- According to Musaffa’s Shariah screening methodology, Carmat SA (ALCAR.PA) is currently classified as NOT HALAL as of July 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.